Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

Hundreds of people with a rare form of blood cancer could be set to benefit after NICE recommended a new targeted treatment ...

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

For example, if a patient relapses after receiving three different treatments, their life expectancy will reduce to less than 10 months. 3 For the 24,000 people living with multiple myeloma in the ...

Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...

he can now tell a 75-year-old who is newly diagnosed with multiple myeloma that they are unlikely to die from it. "Bringing life expectancy for an elderly patient to a normal life expectancy ...

4, 2024 — A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma.

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

The preacher was diagnosed with Multiple Myeloma in 2018 and immediately ... and the average life expectancy is approximately six years. Regular check-ups, adherence to treatment plans, and ...

The FDA has granted LBL-034 orphan drug designation for relapsed/refractory multiple myeloma treatment. LBL-034 has received ...

Multiple myeloma is a type of cancer where plasma cells in bone marrow replicate out of control. Doctors use the acronym CRAB to diagnose myeloma by identifying four symptoms. The National Cancer ...

Multiple myeloma is the second most common hematologic malignancy, but there is a treatment gap for patients with disease ...